http://orcid.org/0000-0003-2181-8250
References
- Costa R, Oliveira NG, Dinis-Oliveira RJ. Pharmacokinetic and pharcodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metab Rev. 2019;51(3):293–313.
- Balit CR, Lynch CN, Isbister GK. Bupropion poisoning: a case series. Med J Aust. 2003;178(2):61–63.
- Murray B, Carpenter J, Dunkley C, et al. Single-agent bupropion exposures: clinical characteristics and an atypical cause of serotonin toxicity. J Med Toxicol. 2020;16(1):12–16.
- Thorpe EL, Pizon AF, Lynch MJ, et al. Bupropion induced serotonin syndrome: a case report. J Med Toxicol. 2010;6(2):168–171.
- Munhoz RP. Serotonin syndrome induced by a combination of bupropion and SSRIs. Clin Neuropharmacol. 2004;27(5):219–222.
- Dunkley EJC, Isbister GK, Sibbritt D, et al. The Huner Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635–642.
- El Mansari M, Ghanbari R, Janssen S, et al. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain. Neuropharmacology. 2008;55(7):1191–1198.
- Ghanbari R, El Mansari M, Blier P. Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion. Pyschopharmacology. 2011;217(1):61–73.
- Starr P, Klein-Schwartz W, Spiller H, et al. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009;27(8):911–915.
- Lewis JC, Sutter ME, Albertson TE, et al. An 11-year review of bupropion insufflation exposures in adults reported to the California Poison Control System. Clin Toxicol (Phila). 2014;52(9):969–972.